TwinStrand wins patent lawsuit, GSK's hepatitis B drug gains Japan approval
TwinStrand Biosciences, a University of Washington spinout, announced it won a patent infringement lawsuit against a California-based competitor. Separately, GSK's hepatitis B drug received approval in Japan. The two developments were reported in the same news brief.
Related stories
J&J's Imaavy becomes first approved therapy for rare anemia · Drug development
Pre-Approved Breast MRI Still Leaves Patient With Surprise Bill · Healthcare systems
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “TwinStrand wins patent case; GSK’s hepatitis B drug approved in Japan.” Browse more stories.